JFG
NVAX icon

Jefferies Financial Group’s Novavax NVAX Stock Holding History

Jefferies Financial Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-65,300
Closed -$525K – 1884
2024
Q4 		$525K Hold
65,300
– – ﹤0.01% 1086
2024
Q3 		$825K Sell
65,300
-6,600
-9% -$85.2K 0.01% 835
2024
Q2 		$910K Buy
71,900
+6,600
+10% +$66.4K 0.01% 783
2024
Q1 		$312K Buy
65,300
+9,000
+16% +$41.7K ﹤0.01% 1202
2023
Q4 		$270K Buy
+56,300
New +$345K ﹤0.01% 1395
2023
Q1 		– Sell
-22,400
Closed -$230K – 1876
2022
Q4 		$230K Buy
+22,400
New +$395K ﹤0.01% 1264

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $605M AUM 43.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Jefferies Financial Group's NVAX Position: Q2 2026 in Review

Jefferies Financial Group sold out of Novavax (NVAX) in Q2 2026, closing a stake of 673,120 shares — an estimated $5.48M sold.

Jefferies Financial Group first reported a position in NVAX in Q4 2022 and held it in 8 quarters. The position peaked at $5.48M in Q1 2026. 268 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Jefferies Financial Group reported no remaining Novavax position as of Q2 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 673,120 Novavax shares in Q2 2026, an estimated $5.48M.
  • Jefferies Financial Group first reported a position in Novavax in Q4 2022 and held it in 8 quarters.
  • Jefferies Financial Group's Novavax position peaked at $5.48M in Q1 2026.
  • 268 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.